To study the effectiveness of Tablet Fluuconazole in superficial fungal infection (Tinea Corporis)
Phase 2
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2020/05/025442
- Lead Sponsor
- Dr ASVINI J
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Single or multiple annular erythematous plaques
2.KOH mount positive for Tinea corporis
3.No previpous exposure to Fluconazole
4.Comorbidities like Diabetes mellitus, obesity and other endocrine disorders.
Exclusion Criteria
1.Large cofluent lesions.
2.History of previous exposure to Fluconazole
3.Patients on medications like steroide, antihistamines, aspirin, immunomodulators,statins,NSAIDS.
4.Patients on chronic medications for TB, HIV, Leprosy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method